Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer J Wolf

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|December 2, 2017
Multiplex single-cell visualization of nucleic acids and protein during HIV infectionMaritza Puray-Chavez, Philip R Tedbury, Andrew D Huber, et al.
The Journal of Clinical Investigation|September 8, 2020
Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistenceCaleb J Studstill, Curtis J Pritzl, Young-Jin Seo, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
Msphere|April 20, 2018
The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected CellsAndrew D Huber, Jennifer J Wolf, Dandan Liu, et al.
ACS Infectious Diseases|December 25, 2018
Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral CoresAndrew D Huber, Dallas L Pineda, Dandan Liu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|December 2, 2017
Multiplex single-cell visualization of nucleic acids and protein during HIV infectionMaritza Puray-Chavez, Philip R Tedbury, Andrew D Huber, et al.
The Journal of Clinical Investigation|September 8, 2020
Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistenceCaleb J Studstill, Curtis J Pritzl, Young-Jin Seo, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
Msphere|April 20, 2018
The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected CellsAndrew D Huber, Jennifer J Wolf, Dandan Liu, et al.
ACS Infectious Diseases|December 25, 2018
Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral CoresAndrew D Huber, Dallas L Pineda, Dandan Liu, et al.
Pageof 2